Skip to main content
logo
LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China flag China · Delayed Price · Currency is CNY
14.49
-0.11 (-0.75%)
Oct 29, 2026, 3:00 PM CST

SHA:603883 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
470.9381.85519.06929.02784.96669.24
Depreciation & Amortization
1,3441,3441,4731,3341,1951,100
Other Amortization
279.14279.14184.68133.58132.6116.15
Loss (Gain) From Sale of Assets
3.543.544.53-5.51-1.44-4.66
Asset Writedown & Restructuring Costs
238.6238.6107.54---
Loss (Gain) From Sale of Investments
-0.9-0.9-2.73-64.66-27.23-33.94
Provision & Write-off of Bad Debts
16.7516.751.0910.597.185.65
Other Operating Activities
257.13299.18354.58405.87427.38313.98
Change in Accounts Receivable
469.25469.25-633.1639.97-804.55-365.08
Change in Inventory
-87.25-87.25576.06-202.63-974.55-226.86
Change in Accounts Payable
218.15218.15-526.47150.81,562721.6
Operating Cash Flow
3,1903,1432,0262,7302,3142,298
Operating Cash Flow Growth
8.95%55.08%-25.77%17.95%0.70%58.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-165.1-253.44-507.5-620.87-308.44-478.61
Sale of Property, Plant & Equipment
5.638.258.247.4811.5819.53
Cash Acquisitions
-2.5-3.2-134.83-529.42-1,505-1,332
Divestitures
0.92-25.9414.128.8660.04
Investment in Securities
-39.978.72-19.72359.8835.95-272.34
Other Investing Activities
-35.913.01-7.54300.621.06
Investing Cash Flow
-236.93-236.66-627.88-761.26-1,457-2,002

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,9043,3611,4961,8393,632
Total Debt Issued
1,0391,9043,3611,4961,8393,632
Short-Term Debt Repaid
-----11.81-1.73
Long-Term Debt Repaid
--3,900-3,728-2,984-3,119-3,418
Lease Payments
-1,201-1,201-1,279-1,303-1,139-1,006
Total Debt Repaid
-3,155-3,900-3,728-2,984-3,131-3,420
Net Debt Issued (Repaid)
-2,116-1,996-367.49-1,488-1,292211.88
Issuance of Common Stock
27.79--6.31,774-
Repurchase of Common Stock
-16.47-16.47-3.86-5.98-14.59-1.27
Common Dividends Paid
-407.07-224.62-714-374.71-302.16-168.23
Other Financing Activities
-443.71-511.76-262.99-565.93-307.88-455.59
Financing Cash Flow
-2,956-2,749-1,348-2,428-142.62-413.21

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
----0.551.7-0.66
Net Cash Flow
-3.09157.1150.23-459.8716.74-117.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,0252,8891,5192,1092,0061,820
Free Cash Flow Growth
19.73%90.21%-27.98%5.14%10.23%72.78%
Free Cash Flow Margin
-12.99%6.79%9.40%9.94%11.59%
Free Cash Flow Per Share
3.933.781.992.792.672.57
Levered Free Cash Flow
-2,3691,4161,6632,2071,671
Unlevered Free Cash Flow
-2,4511,5271,7792,3521,791
Free Cash Flow After Leases
1,8241,688239.62806.09866.71814.17

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
993.59895.13976.07911.78655.76542.13
Change in Working Capital
580.93580.93-615.3-12.8-203.9132.28